DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Nemes Rush Group LLC's Holding History (CIK: 0001982273)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 700 Value ($000) $12 Avg Close $16.88 Range $13.75 - $20.61
Q3 2025
Shares 700 Value ($000) $10 Avg Close $14.37 Range $12.58 - $16.20
Q2 2025
Shares 700 Value ($000) $10 Avg Close $14.07 Range $10.57 - $16.97
Q1 2025
Shares 700 Value ($000) $10 Avg Close $19.16 Range $13.30 - $24.34
Q4 2024
Shares 700 Value ($000) $14 Avg Close $25.60 Range $19.93 - $33.33
Q3 2024
Shares 700 Value ($000) $14 Avg Close $24.79 Range $19.74 - $32.13
Q2 2024
Shares 700 Value ($000) $16 Avg Close $19.20 Range $14.56 - $23.87
Q1 2024
Shares 700 Value ($000) $14 Avg Close $18.79 Range $15.49 - $23.52
Q4 2023
Shares 700 Value ($000) $15 Avg Close $19.81 Range $15.45 - $23.81
Q3 2023
Shares 700 Value ($000) $14 Avg Close $25.37 Range $20.52 - $30.79
Q2 2023
Shares 700 Value ($000) $21 Avg Close $28.12 Range $22.72 - $33.31